Extraesophageal Manifestations and Symptoms of Esophageal Diseases by Širić, Ljiljana et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books








and Symptoms of Esophageal 
Diseases
Ljiljana Širić, Marinela Rosso and Aleksandar Včev
Abstract
Esophageal diseases are diagnosed by gastroenterological processing indicated 
due to typical gastrointestinal symptoms, but typical gastrointestinal symptoms are 
not the only possible manifestation of esophageal disease. There are also external 
symptoms such as chronic cough, laryngitis, pharyngitis, oropharyngeal dyspha-
gia, odynophagia, laryngopharyngeal reflux, dysphonia, sinusitis, ear pain, and 
changes in laryngopharyngeal mucosa (erythema, edema, ventricular obliteration, 
cricoid hyperplasia and pseudosulcus). Extraesophageal symptoms are common in 
esophagitis and GERD, and studies show increasing prevalence of LPR in patients 
with GERD, as well as an association of reflux disease with cough and dysphonia 
symptoms. The aim of the chapter is to describe these extraesophageal symptoms 
of esophageal disease and how to recognize and treat them, in order to facilitate 
gastroenterologists’ diagnostic processing of patients with these symptoms, 
improve their treatment and assessment of the therapy effectiveness, prevent the 
development of stronger symptoms, and encourage multidisciplinary cooperation 
and exchange of knowledge, scientific and clinical work.
Keywords: chronic cough, chronic laryngitis, dysphonia, esophagitis, 
laryngopharyngeal reflux
1. Introduction
Due to anatomical location and function, esophageal motility disorders, 
inflammatory diseases, gastroesophageal reflux (GER), esophageal rings and 
webs, tumors and other esophageal conditions and diseases can cause many 
extraesophageal symptoms, which are increasingly recognised and diagnosed by 
otolaryngologists, pulmonologists, cardiologists, and, of course, gastroenterolo-
gists. Certain pathophysiological conditions that are not localized in the esophagus 
may be the first symptoms of esophageal disease or signs associated with the 
onset of esophageal disease. One of the etiological factors is the pathophysiologi-
cal mechanism of the increase in intra-abdominal pressure that occurs during 
weight gain and in pregnancy. Another etiological factor is the pathophysiological 
mechanism of relaxation of the lower esophageal sphincter that may occur due 
to coronary heart disease drug therapy rich in nitrates. A similar thing happens 
during antirheumatic therapy in rheumatoid arthritis and some degenerative 
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diseases of the locomotor system. Other conditions that may be associated with 
gastroesophageal reflux and esophageal diseases include diabetes mellitus, 
which results in prolonged gastric stagnation and consequent prolonged gastric 
emptying, and duodenal ulcer, duodenal stenosis, or malignant gastric disease 
in which delayed gastric emptying is present. So far, it is a well-known fact that 
the appropriate speed of food passage through the gastrointestinal tract, which is 
conditioned by a series of autoregulatory processes, is important. An optimal rate 
of passage is required - small enough to complete food digestion and absorption 
of substances and large enough to supply the body with the necessary nutrients in 
a timely manner [1]. The most common atypical symptoms of esophageal disease, 
primarily esophagitis and gastroesophageal reflux disease (GERD), will be listed 
here. For better visibility and easier understanding, the classification of atypical 





And last but not least, the biopsychosocial dimensions of esophageal diseases 
and extraesophageal symptoms are being recognized, too.
2. Otolaryngologic manifestations
2.1 Chronic laryngitis and laryngopharyngeal reflux (LPR)
Patients with reflux laryngitis often have characteristic anamnestic data and 
records in the history of the disease. Common symptoms of laryngitis include 
chronic or intermittent recurrent cough, chronic sore throat, hoarseness, clear-
ing of the throat, dry mouth, feeling of a ‘lump’ and tickling in the throat, 
nocturnal dyspnea, laryngospasm and dyspepsia. Inspection of the laryngeal 
mucosa may reveal erythema and edema of the mucosa covering the arytenoid 
cartilage, the posterior part of the larynx, and often the posterior part of the 
true vocal cords.
Figure 1. 
Extraesophageal manifestation of esophageal diseases.
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Two theories explain the pathogenesis of reflux laryngitis:
1. theory of direct injury of the laryngeal mucosa and surrounding tissue by acid 
and pepsin;
2. reflex theory [2].
Due to direct injury to the laryngeal and pharyngeal mucosa, mucociliary trans-
port is damaged and secretions accumulate in the throat, which causes additional 
irritation of the mucosa and contributes to the symptoms of postnasal drip, throat 
clearing and foreign body sensation in the throat. As the larynx lacks the protec-
tive external cleansing and salivary mechanisms that neutralize acid, gastric reflux 
remains undiluted for a long time, resulting in tissue injury. The action of pepsin 
leads to the depletion of the carbonic anhydrase isoenzyme III, and it catalyzes the 
reversible hydration of carbon dioxide resulting in the production of bicarbonate 
ions. The formation of bicarbonate ions directly neutralizes the acidic stomach 
contents and inactivates pepsin, so the ions actually protect the tissue from acid 
refluxate [3, 4]. On the other hand, depletion of carbonic anhydrase isoenzyme III 
reduces the neutralization of acidic gastric contents and allows its prolonged activ-
ity. According to the reflex theory, laryngopharyngeal reflux occurs due to esopha-
geal reflux that stimulates vagal-mediated reflexes, resulting in a subjective need to 
‘clear’ the throat and a chronic cough that leads to injury to the laryngeal mucosa. 
Laryngopharyngeal reflux is a clinical entity that represents the return of gastric 
contents to the space of the larynx and hypopharynx, which causes the contact of 
acid with the tissues of the upper aerodigestive tract [5]. In the physiological state, 
the upper and lower esophageal sphincters act together and prevent reflux of gastric 
contents into the esophagus and upper aerodigestive tract. Howewer, the patho-
physiology of LPR is typically attributed to a defect or dysfunction of the upper 
esophageal sphincter. The esophagus features a number of protective mechanisms 
which prevent injury of the mucosa, which the laryngopharyngeal mucosa do not 
possess, and are more susceptible to damage from acid reflux. Laryngeal epithe-
lium is up to 100 times more susceptible to pepsin damage than esophageal tissue 
[6]. Regurgitation of the contents may cause primary burning and/or sore throat, 
cough, need for excessive throat cleansing, and secondarily may cause symptoms 
such as dysphonia, productive expectoration and globus hystericus (feeling of a 
‘lump’ in the throat). Signs of laryngopharyngeal reflux are visible in the form of 
laryngeal irritations, hyperemic mucosa of the vocal cords and arytenoids, thinned 
vocal cords, posterior pharyngeal wall abnormalities, erythema, edema, and 
discontinuity of mucosal continuity. Of these symptoms, laryngeal irritations and 
abnormalities of the posterior pharyngeal wall have a statistically significant preva-
lence in patients with reflux. It should be noted that these symptoms, in addition to 
esophagitis and gastroesophageal reflux disease, are also present in persons exposed 
to allergens and irritants and in postnasal drip syndrome. Most authors interpret 
laryngopharyngeal reflux as atypical gastroesophageal reflux, although some 
authors disagree with this interpretation given the different pathophysiology and 
symptomatology of these refluxes [7]. It is important to emphasize that the etiology 
of reflux in laryngopharyngeal and gastroesophageal reflux is not the same, just 
as the form and circumstances of occurrence are not quite the same. For example, 
laryngopharyngeal reflux occurs more often during the day in an upright position, 
while gastroesophageal reflux occurs in a horizontal position and at night, or during 
sleep. Different body composition of patients with laryngopharyngeal and gastro-
esophageal reflux [8] was also observed, and published studies show an association 
between increased body mass index (identified as obesity) and gastroesophageal 
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reflux disease [9] and a statistically significant higher incidence of gastroesophageal 
reflux disease in patients with registered obesity. In contrast, increased body mass 
index is not statistically significant in patients suffering from laryngopharyngeal 
reflux [10, 11]. Reflux associated with laryngeal symptoms is verified by laryngos-
copy and 24-hour pH monitoring. Patients with laryngopharyngeal reflux without 
alarming symptoms are treated empirically with proton pump inhibitors for one to 
two months. If this type of therapy is effective, according to individual needs, the 
therapy is extended to six months with the aim of complete healing of the laryngeal 
and pharyngeal mucosa.
2.2 Dysphonia
Chronic gastroesophageal reflux is an etiological factor that contributes to the 
manifestation of laryngeal symptoms, primarily hoarseness. In addition to hoarse-
ness, laryngopharyngeal reflux and laryngitis may occur. Koufman et al. found that 
78% of dysphonic patients have gastroesophageal reflux disease [12]. According to 
Vashana, acid reflux is especially common in singers. The author explains this state-
ment in several facts: muscle activity due to a vocal technique that works against 
the lower esophageal sphincter; inadequate feeding and sleep dynamics; emotional 
components and exposure to stressors typical of this profession [13].
2.3 Chronic rhinosinusitis (CRS)
More recent studies has reported significant association between gastro-
esophageal reflux and chronic rhinosinusitis, but the nature of the association is 
still unknown. Gastroesophageal reflux disease can cause several upper airway 
symptoms and change the physiology of nasopharyngeal mucosa, while upper 
airway diseases might also exacerbate GERD symptoms [14]. This associaton can 
be explained by three physiological mechanisms: the direct effect of acid or acidic 
vapor in the nasal mucosa, a dysfunction of the autonomous nervous system and 
the presence of Helicobacter pylori. It is known that the direct contact of the acid 
with the nasopharyngeal mucosa results in mucosal edema, with reduction of the 
mucociliary clearance and obstruction of the sinusal ostium. The acid reflux is an 
uncommon event in the nasopharynx and occurs in only 5% of GERD patients. 
Autonomic dysfunction, in this case the increase of the vagal tonus, may partly 
account the hyper-reactivity of the airways to acid. The Heliobacter pylori has 
been identified in the esophagus, palatine and tonsils, saliva and teeth, and is 
not known how its presence can result in some abnormalities of this tissues. 
Retrospective studies describe an improvement of 69 to 89% of the nasosinusal 
symptoms after GER treatment. Despite this knowlege, it is still not possible to 
state that the gastroesophageal reflux is one of the leading risk factors to chronic 
rhinosinuitis, but it must be researched as an unchaining factor when there is no 
other evident etiology. Howewer, GER symptoms are very prevalent in patients 
with chronic rhinosinusitis [15].
2.4 Chronic otitis media (COM)
Chronic otitis media may lead to tympanic membrane perforation as a conse-
quence of unresolved and resistant middle ear infection, blockage of the Eustachian 
tube, insufficiency of ciliary clearance, or an injury to the ear persisting more than 
3 months. Various microorganisms are considered as etiologic agents in COM. 
Other predisposing factors may also play role in persistence of the disease. Many 
recent studies have shown a potential association between gastroesophageal reflux 
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and otitis media chronica [16]. Gastroesophageal reflux can be an inflammatory 
cofactor and can result in upper respiratory tract disorders, including COM in 
pediatric and adult age group. Otitis media with effusion is the most common cause 
of hearing loss in children. The pathogenesis is multifactorial: infections, impaired 
immunologic status, allergic history, anatomical problems, familial predisposition 
and enviromental factors have role in pathogenesis. The angle and length of the 
Eustachian tube are more horizontal and shorter in infants than in adults, and may 
allow reflux of gastric contens from the nasopharynx into the middle ear. It can 
cause to lay the groundwork for mucociliary clearance dysfunction and bacterial 
infections. Some studies found pepsin concentrations in samples from middle ear 
effusions of up to 1000-fold greater in children who undergone myringotomy. It 
was suggested that the GER may be related to glue ear in children. The therapy of 
COM is mainly surgical. Higher level of damage in the middle ear of patients having 
GERD requires appropriate treatment which may positively affect outcomes for 
COM surgery [17].
2.5 Oral mucosal changes
More recent studies have pointed out that extraesophageal symptoms of GERD 
are acidic lesions of the oral mucosa. These lesions are caused by direct acid and 
pepsin exposure, or acidic vapor contact in the oral cavity. GERD was reported to 
be associated with microscopic alterations in the palatal mucosa, such as epithelial 
atrophy, deepening of epithelial crests in connective tissue and a higher prevalence 
of fibroblasts [18]. Mucosal changes are quite common and not pathognomonic 
and specific of patients with gastroesophageal or esophagopharyngeal reflux, but 
erythema of the soft palate and uvula, epithelial atrophy, xerostomia and glositis 
are quite common in GERD patients. Some authors pointed out the presence of 
aphtoid lesions, hoarseness, chronic periodontitis, dry oral mucosa with a keratotic 
appearance of the gingival tissues and the presence of burning mouth. In addi-
tion, persons with GERD may complain of a sour or acidic taste, impaired taste 
(dysgeusia), an oral burning sensation and water brash (flooding of the mouth 
with saliva in response to an esophageal reflux stimulus) [19]. Adequate mucin-rich 
salivary secretions coat all of the internal anatomical surfaces and are essential 
for the protection of the oropharyngeal and esophageal mucosa and the teeth 
from chemical, thermal, mechanical and microbial damage. Saliva also facilitates 
efficient swallowing and speech. Some studies have found a significant association 
between gastroesophageal reflux and hyposalivation. On the other hand, proton 
pump inhibitors can cause hyposalivation. Hyposalivation may result in xerostomia, 
impaired mastication and swallowing, painful mouth, cracked lips and angular 
cheilitis [20].
2.6 Hypersalivation
The quantity of salivation and the quality of saliva can be an indicator of a 
certain disease of the oropharynx and esophagus or it can be an indicator of the 
complication of such conditions. Saliva is produced by the parotid, submandibu-
lar and sublingual glands and the small salivary glands. Sialoreia usually occurs 
in neurological diseases, such as Parkinson’s and Wilson’s disease, Angelman’s 
syndrome, infections, heavy metal poisoning, and can also occur in the secre-
tory phase of the menstrual cycle or as idiopathic paroxysmal sialoreia. Increased 
salivation can be caused by systemic consumption of drugs with a cholinergic effect 
(clozapine, risperidone, nitrazepam, lithium and bethanekol), and it also occurs 
as a subtle manifestation of gastroesophageal reflux disease in the form of ‘water 
Gastritis
6
brash’. However, hypersalivation, although uncomfortable and disruptive, does 
not necessarily have to be negative since saliva plays an important role in protect-
ing the esophageal mucosa. There are studies on the importance of ingested saliva 
that neutralizes the pH of gastric acid regurgitated into the esophagus [21] and on 
the buffering of gastric acid that enters the esophagus by reflux [22]. The acid that 
accumulates in the upper part of the esophagus reflexively initiates the formation of 
saliva [23], which is not the case when the acid accumulates in the lower part of the 
esophagus [24].
2.7 Dental erosion
Chronic regurgitation of gastric acids in patients with gastroesophageal reflux 
and related condition - laryngopharyngeal reflux may cause dental erosion which 
can, in combination with attrition or bruxism, lead to extensive loss of coronal tooth 
tissue. Dental erosion is typically a slowly-progressing and ireversibile phenomenon 
defined as the loss of tooth substance by chemical processes (acid exposure) not 
involving bacteria [25]. The literature shows a strong correlation between GERD 
and dental erosion, with a median prevalence of 24% in a large range of age groups. 
The degree of erosion due to GERD is related to the duration of the disease, fre-
quency of reflux, the pH and type of acid, and the quality and quantity of saliva. 
Demineralisation and the loss of calcium and phosphate ions from the mineral 
surface of the teeth result in visible defects, and cause significant reduction in 
microhardness which makes the softened surface more prone to mechanical dam-
age [26]. It is recognized that refluxed acid attacks the palatal surfaces of the upper 
incisor teeth first, later, if the condition continues, erosion of the occlusal surfaces 
of the posterior teeth in both arches and the labial or buccal surfaces [27].
2.8 Halitosis
Halitosis is an unpleasant odor from the oral cavity and is a condition that 
affects a large number of people [28]. The prevalence of halitosis is 8–46% [29]. 
The pathophysiological mechanism of halitosis is still not completely clear and 
is mainly attributed to oral pathology due to microbial activity in the interdental 
space, between the teeth and periodontium, and on the dorsal side of the tongue. 
Published data suggest that halitosis may correlate with chronic sinusitis, upper 
and lower respiratory tract diseases, various systemic diseases, gastroenterological 
diseases, and consumption of certain drugs in patients without oral pathology. It has 
been stated that mouth breathing, too, can be the cause of halitosis [30]. Although 
halitosis has previously been considered a rare consequence of gastrointestinal 
disorders [31], recent literal data have shown that it is common in gastrointestinal 
pathology and is significantly more common in patients with gastroesophageal 
reflux disease than in healthy individuals [32]. Furthermore, the symptom is often 
present in patients with verified infection with Helicobacter pylori, a bacterium that 
is among the major pathogenic factors of inflammatory and ulcerative changes on 
the gastric mucosa [33–36]. In addition, a high correlation has been demonstrated 
between halitosis and gastroesophageal reflux disease and peptic ulcer disease [37], 
and some authors have linked halitosis to volatile sulfur compounds [30, 38, 39] 
and to the chemical compounds cadaverine, some types of indoles [30]. Cadaverine 
(1,5-pentanediamine) is a toxic diamine formed by tissue putrefaction. Indole (ben-
zopyrrole) is a heterocyclic compound formed by the breakdown of the amino acid 
tryptophan in the digestive tract, however, it is also used in the production of certain 
drugs, fragrances and essential oils [40]. An organic compound from the indole 
family associated with halitosis is skatol (3-methylindole), which occurs naturally 
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in faeces, it is also present in flowers and essential oils (orange and jasmine) in low 
concentrations, and is used as a fixative in many perfumes [41]. A 2006 study by 
Lee et al. reported that Helicobacter pylori produces hydrogen sulfide and methyl 
mercaptan that contribute to halitosis [42], and the bacterium itself is one of the 
main factors in the manifestation of gastrointestinal diseases.
3. Thoracic manifestations
Thoracic manifestations can occur secondary to the wide range of esophageal 
disorders: inflammatory process, infections, trauma and perforation, congenital 
malformations, esophageal motility disorders and benign and malignant neoplasms. 
Complications associated with these diseases and disorders can involve the medias-
tinum, tracheobronchial tree, and lungs. Lower respiratory system and esophagus 
share a common embryological derivation and are anatomically related. Pulmonary 
complications can be associated with high morbidity and mortality. Such complica-
tions can be categorized as:
1. mediastinal complications (due to trauma, perforation, foreign bodies, caustic 
injury, or malignancy);
2. tracheobronchial complications (congenital or acquired tracheoesophageal 
fistulas);
3. pleural complications (esophagopleural fistulas);
4. lung complications (due to GERD, infectious and inflammatory process) [43].
Gastroesophageal reflux disease has been linked to a variety of respiratory 
diseases either as a direct cause, or as a risk factor to the inability to control or 
worsening of the disease. It can cause various pulmonary manifestations and 
nonspecific complaints: chronic cough and fewer, recurrent pneumonia, noncardiac 
chest pain, sputum production and dyspnoea, bronchospasm. Epidemiological 
studies in patients with reflux esophagitis have shown an increased risk for chronic 
bronchitis, chronic obstructive pulmonary disease, pneumonia, and idiopathic 
pulmonary fibrosis. Chronic cough and bronchial asthma are more common 
respiratory manifestations of GERD. Pathological GERD has been described in 30% 
to 80% of patients with asthma. Micro-aspiration of gastric contents and/or vagal 
irritation from gastro esophageal reflux may constitute airway irritants and thus 
represent a potential pathogenic mechanism for acute illness or acute exacerbations 
of chronic pulmonary diseases. Exacerbations of chronic obstructive pulmonary 
disease is twice as high in patients with GERD as in those without GERD symptoms. 
GERD can produce lung disease by two mechanisms: by reflex neural mechanisms 
occuring during reflux events limited to the lower part of esophagus, and direct 
from gastric contents refluxed into the pharynx producing upper airway damage 
and lung disease. While gastroesophageal reflux may increase airways resistance 
and cause inflammation by releasing pro-inflammatory mediators, esophagopha-
ryngeal reflux creates the potential to aspiration and its consequences which varies 
depending of the duration, volume and nature of the aspirate [44]. Chronic cough 
is considered to be a cough that is continuously present for eight weeks and longer. 
Among the etiological factors, the three most common causes of chronic cough 
can be singled out: postnasal drip syndrome, asthma and gastroesophageal reflux. 
In 75% of cases, patients with chronic cough do not have the typical symptoms of 
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esophagitis or gastroesophageal reflux disease, yet the result of 25% of patients with 
symptoms of both types speaks in favor of the association of chronic cough and 
esophageal disease [45]. Namely, the determination of correlation is primarily based 
on the strength and direction of the correlation, and not only on the frequency and 
percentage of results.
4. Cardiac manifestations
Coronary heart disease and gastroesophageal reflux disease can interact and 
produce chest pain. Some recent studies have shown that exposure of the esopha-
geal mucosa to acid can compromise myocardial perfusion and cause chest pain 
by inducing coronary spasm or cardiac dysrythmia [46–48]. On the other hand, 
myocardial ischemia can cause esophageal dysmotility or relaxation of the lower 
esophageal sphincter and exacerbate GERD [49]. GERD can worsen sleep distur-
bances, and sleep apnea increases the risk of a cardiovascular diseases [50]. These 
two diseases have a number of common risk factors and comorbidities, such as 
diabetes, hypertension, hyperlipidemia, smoking and alcoholism, gender and age 
[51, 52]. Proton pump inhibitors, as a treatment option in GERD therapy can also 
affect cardiovascular physiology. One of the big population-based study shows that 
PPI usage can reduce the cardioprotective effects of certain therapies, and it can 
also reduce the contractility of myocardial tissue and raise the risk of atherosclerosis 
by increasing the serum levels of homocysteine by impairing the absorption of 
vitamin B12. This study indicates that GERD is associated with an increased risk of 
developing coronary heart disease, and PPI therapy that lasts longer than one year 
might increase the risk of CHD [53].
5. Conclusion
Esophageal symptoms are common and often overlap between different esopha-
geal disorders, making a diagnosis based solely on patient history, symptoms, and 
physical presentation challenging. Esophageal motility disorders often manifest 
with chest pain and dysphagia. Other symptoms are heartburn, regurgitation, 
weight loss and malnutrition. Chest pain is localized behind the sternum, and 
does not spread to the shoulders and arms, which distinguishes it from cardiac 
pain. Gastroesophageal reflux (GER) symptoms have been reported in up to 20% 
of the adult population, which makes GER one of the common gastrointestinal 
disorders with a chronic or recurrent nature. Patients often complain of heartburn 
and acid regurgitation. The presence of this symptoms at least once a week for 
the last 3 months are considered essential in diagnosis of a clinical disorder called 
gastroesophageal reflux disease (GERD) [54]. Gastroesophageal reflux is often 
associated with symptoms of the respiratory tract. Chronic cough of unknown 
origin, laryngeal complaints, throat discomfort, breathing disorders, bronchitis, 
pneumonia and even non allergic asthma, resistant to steroid therapy, are suspi-
cious of being reflux related. Other symptoms are haematemesis, eructation, 
dysphagia, odynophagia, hiccups, changes in the oral, nasal and pharyngeal 
mucosa, dental erosions and cardiac problems. Laryngopharyngeal reflux (LPR) is 
present in up to 60% of GERD patients. Symptoms of this multifactorial syndrome 
are mainly extraesophageal, and are found in the head and neck region. The most 
common symptoms are cough, hoarseness, dysphonia, sore throat, globus pharyn-
geus, chronic postnasal drip, and Eustachian tube dysfunction, Some studies have 
shown that LPR has been associated with vocal cord polyps, vocal cord granulomas, 
9
Extraesophageal Manifestations and Symptoms of Esophageal Diseases
DOI: http://dx.doi.org/10.5772/intechopen.96751
laryngospasm, subglottic stenosis and laryngeal carcinoma [55]. Esophagitis can be 
caused by reflux mechanism, infections, caustic agents, ionizing radiation, thermal 
injuries, eating disorders, medications, and as a part of some sistemic diseases. 
The most common symptoms are dysphagia and odynophagia, heartburn and acid 
regurgitation, haematemesis. Severe and prolonged vomiting and straining can 
results in tears in the mucous membrane of the esophagus. This condition is called 
Mallory-Weiss Syndrome. The main symptoms are hematemesis and melena, and 
in severe cases heavier bleeding may occur. Ribs and webs are the most common 
structural abnormalities of the esophagus. Most of them are asymptomatic, but can 
occasionally present with intermittent dysphagia to solids. They are associated with 
Zenker’s diverticulum and Plummer-Vinson Syndrome which is classically a triad 
of dysphagia, iron-deficiency anemia, and esophageal webs. Esophageal rings are 
almost always associated with a hiatal hernia [56]. The esophagus is the most com-
mon site of acute foreign body obstruction. The clinical presentation varies from 
mild to extremely severe, and the most common symptoms are hypersalivation and 
odynophagia [57]. Esophageal perforation is a rare and potentially life-threatening 
condition most commonly caused by manipulations with medical instruments, 
forced strining and foreign bodies. The most common symptoms are odynophagia, 
chest pain, vomiting and shortness of breath, and in 70% of patients with perfora-
tion of the intrathoracic esophagus there are pleuromediastinum and palpable 
crepitus in the soft tissue of the neck and thorax. Caustic injuries of the esophagus 
are potentially one of the most challenging clinical situations in gastroenterology. 
Caustics and corrosives cause tissue injury by a chemical reaction. The severity of 
injury and the clinical presentation depends on several aspects: Concentration of 
the substance, amount ingested, duration of tissue contact, location of damage, 
and pH of the agent: hoarseness, stridor, dysphagia, odynophagia, hematemesis, 
epigastric pain. Short-term complications include perforation and death [58, 59]. 
Esophageal cancer is the sixth most common cause of cancer deaths worldwide. In 
the initial stage it usually shows no symptoms. The most common symptoms are 
dysphagia, chest pain, pressure or burning, heartburn, coughing or hoarseness, 
weight loss, bleeding, and hiccups. As can be seen, almost all esophageal diseases 
shows atypical and extraesophageal symptomatology. Due to proper and accurate 
diagnosis and treatment, the cooperation of a multidisciplinary team is required.
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